Bing

SEARCH HISTORY

Ligand Pharmaceuticals (NASDAQ:LGND) COO Matthew W. Foehr sold 12,500 shares of Ligand Pharmaceuticals stock in a transaction dated Friday, June 26th. The stock was sold at an average price of $100.97, for a total transaction of $1,262,125.00.
Ticker Report · 1 day ago
Ligand Pharmaceuticals (NASDAQ:LGND)‘s stock had its “buy” rating restated by research analysts at Roth Capital in a report released on Tuesday. They currently have a $135.00 price objective on the biotechnology company’s stock. Roth …
wkrb13.com · 6/24/2015
Ligand Pharmaceuticals (NASDAQ:LGND) COO Matthew W. Foehr sold 23,046 shares of the company’s stock in a transaction dated Monday, June 22nd. The shares were sold at an average price of $96.45, for a total transaction of $2,222,786.70.
Mideast Times · 6/25/2015
More from Bing News
Ligand Pharmaceuticals Incorporated (LGND - Analyst Report) is a biotechnology company that could be an interesting play for investors. That is because, not only does the stock have decent short-term momentum, but it is seeing solid activity on the ...
ZACKS · 6/25/2015
Ligand Pharmaceuticals COO Sells Shares: Ligand Pharmaceuticals (NASDAQ:LGND) COO Matthew W ... Vice President and General Counsel Alicia Hager sold 1,800 shares of OMED common stock at $22.67. The total transaction value was $40,798.
Seeking Alpha · 19 hours ago
FDA
Today, shares of Ligand Pharmaceuticals (NASDAQ:LGND) have advanced above their 10-day MA of $ ... 18.9% above its average consensus analyst price target of $81.80. The stock should find initial support at its 50-day moving average (MA) of $88.68 and ...
Financial News Network Online · ByMallory Stone · 1 day ago
Ligand Pharmaceuticals Inc (LGND): LGND stock is up 1.1% today ... Article printed from InvestorPlace Media, http://investorplace.com/2015/06/hottest-healthcare-stocks-now-mnkd-brli-opk-lgnd-mnkd-brli-opk/.
Investor Place · 6/8/2015
Ligand Pharmaceuticals (NASDAQ:LGND) Director Jason Aryeh sold 1,640 shares of the company’s stock in a transaction that occurred on Thursday, June 4th. The stock was sold at an average price of $92.68, for a total value of $151,995.20. Following …
sleekmoney.com · 6/10/2015
One stock that might be an intriguing choice for investors right now is Ligand Pharmaceuticals Incorporated (LGND). This is because this security in the Generic Drugs space is seeing solid earnings estimate revision activity, and is in great company from a ...
Yahoo Finance · 1/2/2014
Marlborough, MA, June 16, 2014 -- Lemelson Capital Management, a private investment management firm, today announced that it is short Ligand Pharmaceuticals Inc. (NASDAQ:LGND), a biotechnology ... any intrinsic value of the stock. These include …
Value Walk · 6/16/2014